cdmo.directory
← Compare landing

Biomay AG vs Synthego

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBiomay AGSynthego
SummaryGMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.Synthego manufactures GMP-grade CRISPR components and molecular biology reagents for clinical and research applications, with 19 INDs cleared and 200+ clinical sgRNA batches produced.
Services
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • mRNA
  • Gene Therapy
  • Cell Therapy
  • Gene Therapy
Development capabilities
  • Formulation development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Expression: Mammalian
  • Expression: Microbial
  • Drug Substance (DS)
  • Expression: Cell-Free
Locations
  • Headquarters, Vienna, Austria
Data not yet provided.
Certifications
  • EMA · Identifier: GMP
Data not yet provided.

Find similar companies

Biomay AG alternatives · Synthego alternatives

Markdown mirror: /compare/biomay/synthego.md